Journey Medical

DERMNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$177.047 M

$6.43 -1.53%

Close of 7 Aug 2026

Revenue

$61.9M

#2676 by revenue

Earnings

-$11.4M

Loss-making

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#274Corbus PharmaceuticalsCRBP$188.4M
#275Oramed PharmaceuticalsORMP$178.9M
#276Journey MedicalDERM$177.0M
#277Aardvark TherapeuticsAARD$172.9M
#278NkartaNKTX$172.4M

Where these numbers come from

Share counts and financials for Journey Medical are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.